Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Bowers Lisa — DICE Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Bowers Lisa

Bowers Lisa

Director at DICE Therapeutics, Inc. · on record since Apr 1, 2022

Insider trading activity of Bowers Lisa

Transactions on record: 2; since Apr 1, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 9, 2023

Figures computed from official regulatory filings — methodology.

Companies where Bowers Lisa has traded

DICE Therapeutics, Inc.2 tx · Aug 9, 2023

Track record of Bowers Lisa

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Bowers Lisa

Co-insiders of Bowers Lisa

Doyle MittieDICE Therapeutics, Inc.
Gandhi Shaan-Chirag CDICE Therapeutics, Inc.
Jacobsen John R.DICE Therapeutics, Inc.
Judice KevinDICE Therapeutics, Inc.
Kolchinsky PeterDICE Therapeutics, Inc.
Northpond Ventures GP II, LLCDICE Therapeutics, Inc.
Northpond Ventures GP, LLCDICE Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Northpond Ventures II, LPDICE Therapeutics, Inc.

Northpond Ventures, LPDICE Therapeutics, Inc.

RA Capital Biotech Fund LPDICE Therapeutics, Inc.

RA CAPITAL MANAGEMENT, LLCDICE Therapeutics, Inc.

RA Capital Nexus Fund II, L.P.DICE Therapeutics, Inc.

Robertson Scott M.DICE Therapeutics, Inc.

Rubin Michael P.DICE Therapeutics, Inc.

SCHELLER RICHARD HDICE Therapeutics, Inc.

Scopa James PaulDICE Therapeutics, Inc.

Shah Rajeev M.DICE Therapeutics, Inc.

Simson JakeDICE Therapeutics, Inc.

TETLOW SHARONDICE Therapeutics, Inc.

Timothy LuDICE Therapeutics, Inc.

Zachary StephenDICE Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
DICE Therapeutics, Inc.	Aug 9, 2023	OtherD	-42,500	—	—	SEC
DICE Therapeutics, Inc.	Apr 1, 2022	AwardD	42,500	0.00 USD	$0	SEC